TrialGene therapy2006

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.

D J Stewart et al.PubMed ↗Publisher ↗

No numbers read from the abstract.